This Biotech ETF Is “Prime Hunting Ground” For Big Pharma Companies Looking For Takeover Targets
Industry analysts expect M&A activity in the biotech space to accelerate in the back half of 2021 – and that could drive the ETF highlighted… Read More »This Biotech ETF Is “Prime Hunting Ground” For Big Pharma Companies Looking For Takeover Targets